PCHM News and Press, Pharmchem Inc

PharmChem, Inc. Announces Shareholder Approval of Acquisition by Alcohol Monitoring Systems, Inc. PR Newswire FORT WORTH, Texas , Aug. 27, 2025 /PRNewswire/ -- PharmChem, Inc. ("PharmChem" or the "Company") (OTC: PCHM) is pleased to announce that its acquisition ...

SOPHiA GENETICS SA (SOPH) is expected to report for Q2 2025 Investors Title Company (ITIC) is expected to report for Q2 2025 Safehold Inc. (SAFE) is expected to report $0.39 for Q2 2025 First Guaranty Bancshares Inc. (FGBI) is expected to report $-0.2 for Q2 2025 United Fire Group...

2025-07-24 10:25:00 ET Dear Partners and Friends: The major indices made a strong recovery in the second quarter. The ones that suffered the most in the first quarter increased the most in the second quarter. The NASDAQ rose 17.7% in Q2 after declining 10.4% in Q1, while the S&P...

2025-07-21 08:38:35 ET More on PharmChem, Inc. Financial information for PharmChem, Inc. Read the full article on Seeking Alpha For further details see: PharmChem announces acquisition by Alcohol Monitoring Systems

PharmChem, Inc. Announces Acquisition by Alcohol Monitoring Systems, Inc. PR Newswire FORT WORTH, Texas , July 21, 2025 /PRNewswire/ -- PharmChem, Inc.("PharmChem" or the "Company") (OTC: PCHM) the leading provider of sweat patches to detect drugs of abuse, today...

Cyclerion Therapeutics Inc. (CYCN) is expected to report for Q1 2025 Standard BioTools Inc. (LAB) is expected to report $-0.06 for Q1 2025 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2025 CF Bankshares Inc. (CFBK) is expected to report for Q1 2025 Jack Henry & A...

Extra Space Storage Inc (EXR) is expected to report $1.97 for Q1 2025 DAQO New Energy Corp. American Depositary Shares each representing five (DQ) is expected to report $-1.02 for Q1 2025 MAC Copper Limited (MTAL) is expected to report $0.22 for Q1 2025 United States Lime & Minera...

2025-04-16 00:30:00 ET Summary Cedar Creek’s average annual return over our 19-year history is 14.3%, net of fees and expenses, which compares favorably to all the indices we compare against. On the whole, as of the end of March 2025, the fund’s holdings were trading...

2025-02-11 05:10:00 ET Summary Cedar Creek’s average annual return over our 19 year history is 14.0%, net of fees and expenses, which compares favorably to all the indices we compare against. We started the quarter with cash levels at 3% and ended the quarter at 8% largely ...

2025-02-03 09:03:12 ET Read the full article on Seeking Alpha For further details see: PharmChem explores strategic alternatives